ASN's Mission

To create a world without kidney diseases, the ASN Alliance for Kidney Health elevates care by educating and informing, driving breakthroughs and innovation, and advocating for policies that create transformative changes in kidney medicine throughout the world.

learn more

Contact ASN

1401 H St, NW, Ste 900, Washington, DC 20005

email@asn-online.org

202-640-4660

The Latest on X

Kidney Week

Please note that you are viewing an archived section from 2019 and some content may be unavailable. To unlock all content for 2019, please visit the archives.

Abstract: SA-PO632

Success and Safety of Native Kidney Biopsies Guided and Performed by Nephrologists

Session Information

Category: Glomerular Diseases

  • 1203 Glomerular Diseases: Clinical, Outcomes, and Trials

Authors

  • Palacherla, Jith, Emory University, Atlanta, Georgia, United States
  • O'Neill, W. Charles, Emory University, Atlanta, Georgia, United States
Background

Percutaneous kidney biopsy is a key procedure in nephrology and a requirement for training, but is often not performed by nephrologists, even in training programs. The reasons are manifold but include concerns about competence and safety, particularly the perceived need for real-time ultrasound guidance. To address this, we examined the outcomes of ultrasound-guided biopsies performed in their entirety by nephrologists at this institution.

Methods

All native kidney biopsies performed by the Renal Division at Emory University Hospital for clinical indications from 1/1/2008 to 9/30/2018 were identified from a database of ultrasound studies performed by the Division. Medical records were reviewed to determine clinical characteristics and outcomes. Large hematomas, gross hematuria, hypotension, transfusion, or endovascular intervention were considered clinically important complications.

Results

We identified 422 biopsies that were performed by 70 trainees (1-12 procedures each; median: 5) with the supervision or assistance of 22 faculty (1-105 procedures each; median: 5). Forty three were performed by faculty alone. Patient age was 45.6 + 0.8 (13-84) and body mass index (BMI) 27.2 + 0.3 kg/m2 (16.2-52.3). All biopsies were performed with a Monopty 18g device with a 1.7 cm sampling length (Bard Peripheral Vascular, Tempe, AZ). In 93%, the kidney was located by ultrasound prior to but not during the biopsy, with an 18.8 cm, 20g needle used to confirm the location and provide deep anesthesia. In 7%, ultrasound was used during the procedure (real-time guidance). Other characteristics of the biopsies were: left kidney 91%; prone position 99%; end-inspiration 51%; end-expiration 44%; depth 5.4 + 0.08 cm (2-11). Tissue was obtained in 98.6% (adequate for diagnosis in 96.9%) with 3.56 +0.07 (1-10) passes and 2.54 + 0.04 (1-5) tissue cores. The BMI was 40 kg/m2 or greater in 2 of the 6 unsuccessful procedures. Clinically significant complications occurred in 7 patients (1.7%), requiring transfusions in 3 and intervention in 2. These patients did not differ in characteristics or biopsy parameters from those with no complications.

Conclusion

Percutaneous renal biopsies can be performed in their entirety by nephrologists with excellent success and complication rates. Real-time ultrasound guidance is not essential and should not deter nephrologists from performing this important procedure.

Funding

  • Clinical Revenue Support